Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y, Kobayashi H, Iida T, Asai N, Masamune A, Hara A, Esaki N, Ushida K, Mii S, Shiraki Y, Ando K, Weng L, Ishihara S, Ponik SM, Conklin MW, Haga H, Nagasaka A, Miyata T, Matsuyama M, Kobayashi T, Fujii T, Yamada S, Yamaguchi J, Wang T, Woods SL, Worthley D, Shimamura T, Fujishiro M, Hirooka Y, Enomoto A, Takahashi M. Mizutani Y, et al. Among authors: yamaguchi j. Cancer Res. 2019 Oct 15;79(20):5367-5381. doi: 10.1158/0008-5472.CAN-19-0454. Epub 2019 Aug 22. Cancer Res. 2019. PMID: 31439548
Cells of origin of pancreatic neoplasms.
Yamaguchi J, Yokoyama Y, Kokuryo T, Ebata T, Nagino M. Yamaguchi J, et al. Surg Today. 2018 Jan;48(1):9-17. doi: 10.1007/s00595-017-1501-2. Epub 2017 Mar 4. Surg Today. 2018. PMID: 28260136 Review.
Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
Yamada S, Fujii T, Yokoyama Y, Kawashima H, Maeda O, Suzuki K, Okada T, Ono E, Yamaguchi J, Takano N, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Kodera Y. Yamada S, et al. Among authors: yamaguchi j. Cancer Chemother Pharmacol. 2018 May;81(5):815-821. doi: 10.1007/s00280-018-3554-3. Epub 2018 Mar 3. Cancer Chemother Pharmacol. 2018. PMID: 29502139 Clinical Trial.
Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study.
Takano N, Yamada S, Hirakawa A, Yokoyama Y, Kawashima H, Maeda O, Okada T, Ohno E, Yamaguchi J, Ishikawa T, Sonohara F, Suenaga M, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Fujii T, Kodera Y. Takano N, et al. Among authors: yamaguchi j. Nagoya J Med Sci. 2019 May;81(2):233-239. doi: 10.18999/nagjms.81.2.233. Nagoya J Med Sci. 2019. PMID: 31239592 Free PMC article. Clinical Trial.
Tumor marker recovery rather than major pathological response is a preferable prognostic factor in patients with pancreatic ductal adenocarcinoma with preoperative therapy.
Yamada S, Yokoyama Y, Sonohara F, Yamaguchi J, Takami H, Hayashi M, Onoe S, Fujii T, Nagino M, Kodera Y. Yamada S, et al. Among authors: yamaguchi j. J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):487-495. doi: 10.1002/jhbp.748. Epub 2020 May 14. J Hepatobiliary Pancreat Sci. 2020. PMID: 32359199
Impact of Qualitative and Quantitative Biliary Contamination Status on the Incidence of Postoperative Infection Complications in Patients Undergoing Pancreatoduodenectomy.
Suenaga M, Yokoyama Y, Fujii T, Yamada S, Yamaguchi J, Hayashi M, Asahara T, Nagino M, Kodera Y. Suenaga M, et al. Among authors: yamaguchi j. Ann Surg Oncol. 2021 Jan;28(1):560-569. doi: 10.1245/s10434-020-08645-w. Epub 2020 May 28. Ann Surg Oncol. 2021. PMID: 32468346 Free PMC article.
1,167 results